|
Volumn 32, Issue 2, 2005, Pages 209-211
|
Safe and effective pharmacologic management of arrhythmias
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
POTASSIUM CHANNEL BLOCKING AGENT;
SODIUM CHANNEL BLOCKING AGENT;
ANTICHOLINERGIC EFFECT;
ASTHMA;
CHRONIC LUNG DISEASE;
CONFERENCE PAPER;
CORNEA DISEASE;
COUGHING;
DISEASE EXACERBATION;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG SAFETY;
DYSPNEA;
FEVER;
GASTROINTESTINAL SYMPTOM;
HEART ARRHYTHMIA;
HEART DISEASE;
HEART PROARRHYTHMIA;
HUMAN;
HYPERTHYROIDISM;
HYPOTHYROIDISM;
LIVER CONGESTION;
LUNG FIBROSIS;
LUNG TOXICITY;
OPTIC NERVE DISEASE;
PARESTHESIA;
PERIPHERAL NEUROPATHY;
PHOTOSENSITIVITY DISORDER;
PNEUMONIA;
QRS COMPLEX;
QT PROLONGATION;
RESPIRATORY FAILURE;
SIDE EFFECT;
SKIN DISEASE;
TASTE DISORDER;
TORSADE DES POINTES;
TOXIC HEPATITIS;
TREMOR;
VISUAL IMPAIRMENT;
AMIODARONE;
ANTI-ARRHYTHMIA AGENTS;
ARRHYTHMIA;
ELECTROCARDIOGRAPHY;
FLECAINIDE;
HUMANS;
POTASSIUM CHANNEL BLOCKERS;
SODIUM CHANNEL BLOCKERS;
|
EID: 20444377303
PISSN: 07302347
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (12)
|
References (0)
|